Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Day One Biopharmaceuticals Inc
(NQ:
DAWN
)
12.83
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
12.83
Bid (Size)
12.57 (3)
Ask (Size)
13.09 (3)
Prev. Close
12.83
Today's Range
12.83 - 12.83
52wk Range
10.84 - 25.77
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Latest Analyst Ratings for Day One Biopharmaceutical
September 12, 2023
Via
Benzinga
Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
September 11, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Performance
YTD
-36.64%
-36.64%
1 Month
-7.30%
-7.30%
3 Month
+6.47%
+6.47%
6 Month
-2.80%
-2.80%
1 Year
-28.88%
-28.88%
More News
Read More
Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience
August 16, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Where Day One Biopharmaceutical Stands With Analysts
August 08, 2023
Via
Benzinga
Day One Reports Second Quarter 2023 Financial Results and Corporate Progress
August 07, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Analyst Ratings for Day One Biopharmaceutical
June 05, 2023
Via
Benzinga
Why Day One Biopharmaceuticals Stock Is Trading Higher Premarket Today
June 05, 2023
Via
Benzinga
$3.6 Bet On Asana? Check Out These 4 Stocks Insiders Are Buying
June 13, 2023
Via
Benzinga
Day One Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
June 12, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Stock Market Rally Broadens Out; Apple Unveils Vision Pro, SEC Sues Binance, Coinbase: Weekly Review
June 09, 2023
Via
Investor's Business Daily
Day One Announces Pricing of Public Offering of Common Stock
June 06, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Day One Announces Proposed Public Offering of Common Stock
June 06, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 05, 2023
Via
Benzinga
Why Shares of Day One Pharmaceuticals Are Up Monday
June 05, 2023
Via
The Motley Fool
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes
June 05, 2023
Via
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 05, 2023
Via
Benzinga
Why Mallinckrodt Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
June 05, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
June 05, 2023
Via
InvestorPlace
Day One Biopharmaceuticals, ImmunoGen And Other Big Stocks Moving Higher In Monday's Pre-Market Session
June 05, 2023
Via
Benzinga
Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma
June 04, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Neurofibromatosis Treatment Market Value Expected to Reach $27 Billion By End Of 2029
June 01, 2023
Via
FinancialNewsMedia
Day One to Participate in the Goldman Sachs 44th Annual Healthcare Conference
May 30, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting’s Oral Presentations
May 26, 2023
Via
FinancialNewsMedia
Exposures
Product Safety
CORRECTION -- Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
May 25, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
May 25, 2023
From
Day One Biopharmaceuticals, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.